Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroids

Leukemia

Volumn 23, Issue 1, 2009, Pages 209-212

  Lonnerholm G ^a   Nordgren, A ^b   Frost, B M ^a   Jonsson, O G ^c   Kanerva, J ^d   Nygaard, R ^e   Schmiegelow, K ^f   Larsson, R ^g   Forestier, E ^h  

^a UNIVERSITY CHILDREN S HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^h UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; ASPARAGINASE; CORTICOSTEROID; CYTARABINE; CYTOTOXIC AGENT; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; PREDNISOLONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AGE DISTRIBUTION; ANIMAL CELL; B CELL LEUKEMIA; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME 20; CHROMOSOME 9; CHROMOSOME BANDING PATTERN; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOGENETICS; CYTOTOXICITY; DRUG INDICATION; DRUG SENSITIVITY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HIGH RISK POPULATION; HUMAN; IMMUNOPHENOTYPING; IN VITRO STUDY; KARYOTYPE; LETTER; LEUKEMIA CELL; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; METAPHASE; MONOSOMY; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE;

EID: 58249101464     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.179     Document Type: Letter

References (12)

1. Rieder H, Schnittger S, Bodenstein H, Schwonzen M, Wormann B, Berkovic D et al. dic(9;20): A new recurrent chromosome abnormality in adult acute lymphoblastic leukemia. Genes Chromosomes Cancer 1995; 13 54-61.
2. Slater R, Smit E, Kroes W, Bellomo MJ, Muhlematter D, Harbott J et al A nonrandom chromosome abnormality found in precursor-B lineage acute lymphoblastic leukaemia: Dic(9;20)(p1?3;q11). Leukemia 1995; 9: 1613-1619.
3. Clark R, Byatt SA, Bennett CF, Brama M, Martineau M, Moorman AV et al Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia. Leukemia 2000; 14: 241-246.
4. Schoumans J, Johansson B, Corcoran M, Kuchinskaya E, Golovleva I, Grander D et al. Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukaemia by tiling resolution array-based comparative genomic hybridisation reveals clustered breakpoints at 9p13.2 and 20q11.2. Br J Haematol 2006; 135: 492-499.
5. Forestier E, Gauffin F, Andersen MK, Autio K, Borgstrom G, Golovleva I et al. Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukemias: A Nordic series of 24 cases and review of the literature. Genes Chromosomes Cancer 2008; 47: 149-158.
6. Mitelman F, Johansson B, Mertens F. Mitelman Database of Chromosome Abberations in Cancer. In: http://cgap.nci.nih.gov/Chromosomes/Mitelman, 17 September 2007.
7. Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G et al. Improving outcome through two decades in childhood ALL in the Nordic countries: The impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia 2000; 14 2267-2275.
8. Nygren P, Kristensen J, Jonsson B, Sundstrom C, Lonnerholm G, Kreuger A et al. Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia. Leukemia 1992; 6 1121-1128.
9. Larsson R, Nygren P. Laboratory prediction of clinical chemotherapeutic drug resistance: A working model exemplified by acute leukaemia. Eur J Cancer 1993; 29A: 1208-1212.
10. Frost BM, Nygren P, Gustafsson G, Forestier E, Jonsson OG, Kanerva J et al. Increased in vitro cellular drug resistance is related to poor outcome in high-risk childhood acute lymphoblastic leukaemia. Br J Haematol 2003; 122: 376-385.
11. Frost BM, Forestier E, Gustafsson G, Nygren P, Hellebostad M, Jonsson OG et al. Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia. Blood 2004; 104: 2452-2457.
12. Frost BM, Forestier E, Gustafsson G, Nygren P, Hellebostad M, Jonmundsson G et al. Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia. Leukemia 2005; 19: 165-169.